OX40 Ligand

OX40 Ligand 분자 정보

영어 이름Tumor necrosis factor ligand superfamily member 4시판 약물 수0
임상 약물 수13표적 별명CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Necrosis Factor Ligand 2B,OX40 Antigen Ligand
최고 연구 개발 단계Phase 3 Clinical
영어 이름Tumor necrosis factor ligand superfamily member 4
표적 별명CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Necrosis Factor Ligand 2B,OX40 Antigen Ligand
시판 약물 수0
임상 약물 수13
최고 연구 개발 단계Phase 3 Clinical

OX40 Ligand분자 배경

Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on such cells as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. The interaction of TNFSF4-TNFSF4 is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. Furthermore, similar to other TNF superfamily members, membrane-bound OX40 Ligand (TNFSF4) exists as a homotrimer. Human TNFSF4 shares 46% amino acid sequence identity with its mouse counterpart.

OX40 Ligand분자 별명

OX40L,TNFSF4,CD252,Glycoprotein Gp34,TXGP1,CD134 ligand,CD134L

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
AmlitelimabKY-1005; SAR-445229Phase 3 ClinicalKymab Ltd, SanofiAlopecia Areata; Asthma; Celiac Disease; Dermatitis, Atopic; Eczema; Hidradenitis; Immune System Diseases; Lung Diseases, Interstitial; Scleroderma, Systemic
상세
APG-279APG279; APG-990/APG777Phase 2 ClinicalApogee Therapeutics IncDermatitis, Atopic
상세
IMB-101 (IMBiologics)IMB-101 (IMBiologics); HDM-3019; IMB101 (IMBiologics); HDM3019; NAV-240Phase 2 ClinicalIMBiologics CorpArthritis, Rheumatoid; Hidradenitis Suppurativa
상세
IBI356IBI-356; IBI356Phase 2 ClinicalAutoimmune Diseases; Dermatitis, Atopic
상세
RP-3RP-3Phase 2 ClinicalReplimune IncBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
HS-130HS-130Phase 1 ClinicalHeat BiologicsSolid tumours
상세
mRNA-2752mRNA-2752Phase 1 ClinicalAstrazeneca Plc, Moderna IncLymphoma; Neoplasms; Solid tumours
상세
MQ-710MQ-710Phase 1 ClinicalImvaq Therapeutics Corp, Memorial Sloan Kettering Cancer CenterAdenocarcinoma, Sebaceous; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hemangiosarcoma; Melanoma; Neoplasm Metastasis; Neoplasms; Paget Disease, Extramammary; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
OX-118OX-118Phase 1 ClinicalOxion Biologics ABAutoimmune Diseases; Immune System Diseases; Rheumatic Diseases
상세
M-5542M5542; M-5542Phase 1 ClinicalMerck & Co Inc
상세
ABCL-575ABCL-575; ABCL575Phase 1 ClinicalAbCellera Biologics IncDermatitis, Atopic
상세
APG-990APG-990; APG990; PR-007; PR007Phase 1 ClinicalParagon Therapeutics IncDermatitis, Atopic
상세
SAR-443726SAR-443726Phase 1 ClinicalSanofiDermatitis, Atopic
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호